By contrast, a recent work carried out on Systemic lupus erythematosus and SSc patients by Janahi and collaborators [56] provides data supporting higher prevalence of HCMV-specific CD4+ than CD8+ T cell responses. This evidence concerns the gene CD8A and systemic sclerosis.